{"DataElement":{"publicId":"64737","version":"3.1","preferredName":"Histologic Nottingham Score Mitosis Assessment Type","preferredDefinition":"a value range describing the rate observed for the microscopic process of cell division in tumor cells reported using the Nottingham Prognostic Index for grade of breast cancer.","longName":"HIST_NS_MIT_ASSES_TP","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2009677","version":"3","preferredName":"Histology Nottingham Score Mitosis Evaluation","preferredDefinition":"related to the outcome from observing the microscopic process of cell division in tumor cells as part of criteria from the Nottingham Prognostic Index to determine the grade of breast cancer.","longName":"HIST_NS_MITOS_ASSESS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2722641","version":"1","preferredName":"Histology Nottingham Score","preferredDefinition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.:The numerical result of analysis of a breast cancer based on the Nottingham Prognostic Index.","longName":"C16681:C25595","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Nottingham Score","conceptCode":"C25595","definition":"A numeric representation combining three histologic reporting elements, tubule formation, nuclear pleomorphism and mitotic count, to determine the grade of breast cancer. The Nottingham Score is a factor in determining the Nottingham Prognostic Index.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44017AE6-67BC-16E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-18","modifiedBy":"ONEDATA","dateModified":"2008-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2722642","version":"1","preferredName":"Mitosis Evaluation","preferredDefinition":"The usual process of somatic reproduction of cells consisting of a sequence of modifications of the nucleus that result in the formation of two daughter cells with exactly the same chromosome and DNA content as that of the original cell. It is the process by which the body grows and replaces cells and is divided into four phases. In Prophase, paired chromosomes form, nuclear membrane disappears, the achromatic spindle appears, and polar bodies form. In Metaphase, chromosomes are arranged in the equatorial plane of the central spindle to form the monaster and chromosomes separate into exactly similar halves. In Anaphase, the two groups of daughter chromosomes separate and move along the fibers of the central spindle, each toward one of the asters, forming the diaster. In Telophase, the daughter chromosomes resolve themselves into a reticulum, the daughter nuclei are formed, and the cytoplasm divides forming two complete daughter cells.:Evaluation; the act of placing value on something.","longName":"C16864:C25214","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mitosis","conceptCode":"C16864","definition":"The usual process of somatic reproduction of cells consisting of a sequence of modifications of the nucleus that result in the formation of two daughter cells with exactly the same chromosome and DNA content as that of the original cell. It is the process by which the body grows and replaces cells and is divided into four phases. In Prophase, paired chromosomes form, nuclear membrane disappears, the achromatic spindle appears, and polar bodies form. In Metaphase, chromosomes are arranged in the equatorial plane of the central spindle to form the monaster and chromosomes separate into exactly similar halves. In Anaphase, the two groups of daughter chromosomes separate and move along the fibers of the central spindle, each toward one of the asters, forming the diaster. In Telophase, the daughter chromosomes resolve themselves into a reticulum, the daughter nuclei are formed, and the cytoplasm divides forming two complete daughter cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Evaluation","conceptCode":"C25214","definition":"Systematic, objective appraisal of the significance, effectiveness, and impact of activities or condition according to specified objectives and criteria.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"44017AE6-67CD-16E4-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-01-18","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-01-18","modifiedBy":"ONEDATA","dateModified":"2008-01-18","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EEDB15-9CF2-2DFB-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2015525","version":"3","preferredName":"Histologic Nottingham Score Mitosis Assessment Type","preferredDefinition":"a value range describing the rate observed for the microscopic process of cell division in tumor cells reported using the Nottingham Prognostic Index for grade of breast cancer.","longName":"HIST_NS_MIT_ASSES_TP","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"1","maxLength":"125","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"0 to 5 mitoses per 10 HPF (0.44 mm) OR 0-9 mitoses per 10 HPF (0.59 mm) OR 0-11 mitoses per 10 HPF (0.63 mm)","valueDescription":"0 TO 5 MITOSES PER 10 HPF (0.44 MM) OR 0-9 MITOSES PER 10 HPF (0.59 MM) OR 0-11 MITOSES PER 10 HPF (0.63 MM) (1 PT)","ValueMeaning":{"publicId":"2558064","version":"1","preferredName":"0 TO 5 MITOSES PER 10 HPF (0.44 MM) OR 0-9 MITOSES PER 10 HPF (0.59 MM) OR 0-11 MITOSES PER 10 HPF (0.63 MM) (1 PT)","longName":"2558064","preferredDefinition":"0 TO 5 MITOSES PER 10 HPF (0.44 MM) OR 0-9 MITOSES PER 10 HPF (0.59 MM) OR 0-11 MITOSES PER 10 HPF (0.63 MM) (1 PT)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-AFDD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17F03E1E-4200-2EFE-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","deletedIndicator":"No"},{"value":"6 to 10 mitoses per 10 HPF (0.44 mm) OR 10-20 mitoses per 10 HPF (0.59 mm) OR 12-23 mitoses per 10 HPF (0.63 mm)","valueDescription":"6 TO 10 MITOSES PER 10 HPF (0.44 MM) OR 10-20 MITOSES PER 10 HPF (0.59 MM) OR 12-23 MITOSES PER 10 HPF (0.63 MM) (2 PTS)","ValueMeaning":{"publicId":"2558094","version":"1","preferredName":"6 TO 10 MITOSES PER 10 HPF (0.44 MM) OR 10-20 MITOSES PER 10 HPF (0.59 MM) OR 12-23 MITOSES PER 10 HPF (0.63 MM) (2 PTS)","longName":"2558094","preferredDefinition":"6 TO 10 MITOSES PER 10 HPF (0.44 MM) OR 10-20 MITOSES PER 10 HPF (0.59 MM) OR 12-23 MITOSES PER 10 HPF (0.63 MM) (2 PTS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-AFFB-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17F03E1E-420A-2EFE-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","deletedIndicator":"No"},{"value":">11 mitoses per 10 HPF (0.44 mm) OR >20 mitoses per 10 HPF (0.59 mm) OR > 23 mitoses per 10 HPF (0.63 mm)","valueDescription":">11 MITOSES PER 10 HPF (0.44 MM) OR >20 MITOSES PER 10 HPF (0.59 MM) OR > 23 MITOSES PER 10 HPF (0.63 MM) (3 PTS)","ValueMeaning":{"publicId":"2558115","version":"1","preferredName":">11 MITOSES PER 10 HPF (0.44 MM) OR >20 MITOSES PER 10 HPF (0.59 MM) OR > 23 MITOSES PER 10 HPF (0.63 MM) (3 PTS)","longName":"2558115","preferredDefinition":">11 MITOSES PER 10 HPF (0.44 MM) OR >20 MITOSES PER 10 HPF (0.59 MM) OR > 23 MITOSES PER 10 HPF (0.63 MM) (3 PTS)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B010-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17F03E1E-4214-2EFE-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","deletedIndicator":"No"},{"value":"Indeterminate","valueDescription":"Indeterminate","ValueMeaning":{"publicId":"2558962","version":"1","preferredName":"Indeterminate","longName":"2558962","preferredDefinition":"Cannot distinguish between two or more possible values in the current context.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Indeterminate","conceptCode":"C48658","definition":"Cannot distinguish between two or more possible values in the current context.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B35F-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"GDEEN","dateModified":"2024-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"17F03E1E-421E-2EFE-E044-0003BA3F9857","beginDate":"2002-02-11","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"ONEDATA","dateModified":"2006-07-06","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2177853","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"Type","context":"CTEP","contextVersion":"2.31","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"C16D625D-02B6-1907-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2003-07-09","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2003-07-09","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17F03E1E-41EC-2EFE-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"REEVESD","dateModified":"2012-10-12","changeDescription":"updated for ISO compliance","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811831","version":"1","longName":"Breast","context":"CTEP"},{"publicId":"2812245","version":"1","longName":"Phase II Breast Cancer","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811953","version":"1","longName":"Disease Description","context":"CTEP"},{"publicId":"2811959","version":"1","longName":"Patient Char.","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811932","version":"1","longName":"Pathology Breast","context":"CTEP"},{"publicId":"2811914","version":"1","longName":"Adjuvant Breast","context":"CTEP"},{"publicId":"2811917","version":"1","longName":"Advanced Breast","context":"CTEP"}]},{"publicId":"2008608","version":"1","longName":"Phase","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811891","version":"1","longName":"Phase II","context":"CTEP"}]}],"AlternateNames":[{"name":"DCP","type":"USED_BY","context":"DCP"}],"ReferenceDocuments":[{"name":"COMMENT_468","type":"COMMENT","description":"[Note: Use for the following field diameters: 0.59 mm (x25 objective Leitz Orthodox); 0.44 mm (x40 objective Nikon Labophot); 0.63 mm (x40 objective Leitz Diaplan)]","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"Mitotic Count Corrected","url":null,"context":"CTEP"},{"name":"Corrected Mitotic Count","type":"Preferred Question Text","description":"Corrected Mitotic Count","url":null,"context":"CTEP"},{"name":"2-COMMENT","type":"COMMENT","description":"versioned due to association with wrong VD at time of initial ISO compliance update; correction made; re-released","url":null,"context":"CTEP"},{"name":"Value List from CAP","type":"DATA_ELEMENT_SOURCE","description":"College of American Pathology; Protocol for Breast Cancer; revision date: January 2005; based on Fitzgibbons, et al. Arch Pathol Lab Med. 2000 Jul;124(7):966-78.","url":null,"context":"CTEP"}],"origin":"CTEP CDE Committee","workflowStatus":"RELEASED","registrationStatus":"Application","id":"17EE96CD-6792-2693-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-06","endDate":null,"createdBy":"PWEST","dateCreated":"2006-07-06","modifiedBy":"LUY","dateModified":"2013-10-23","changeDescription":"versioned due to association with wrong VD at time of initial ISO compliance update; correction made; re-released","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}